Brief: Motus GI Announces Expedite Study Initiated By Boston Medical Center To Evaluate Clinical Effectiveness Of Pure-Vu System
11/11/2019 13:13
Nov 11 (Reuters) - Motus GI Holdings Inc MOTS.O :
* MOTUS GI ANNOUNCES EXPEDITE STUDY INITIATED BY BOSTON
MEDICAL
CENTER TO EVALUATE CLINICAL EFFECTIVENESS OF PURE-VU® SYSTEM FOR
IMPROVING BOWEL PREPARATION RATES
* MOTUS GI HOLDINGS - EXPEDITE STUDY WILL ENROLL UP TO 50
INPATIENTS AND 50 OUTPATIENTS OVER A 12-MONTH STUDY PERIOD
Source text for Eikon: ID:nBw80Mr5ma
Further company coverage: MOTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Motus GI Holdings
See all newsBrief: Motus GI Holdings Inc Continuing To Explore A Range Of Strategic And Financing Alternatives
Brief: Motus Gi Holdings Files Prospectus Related To Resale Of Up To 4.4 Million Shares Of Common Stock, By The Selling Stockholder
Brief: Motus GI Granted A U.S. Patent For Key Feature Embodied By The Pure-Vu System
U.S. STOCKS ON THE MOVE-Chewy, Amgen, Bluebird bio
Brief: Motus Gi Holdings Says Prices Public Offering At $1.50 Per Share